Browse studies

Find your next paid study

27,292 recruiting studies available now

Newest first Highest paying

Phase 1

A Phase 1 Trial Evaluating the Safety, Tolerability, PK, and Efficacy of QTX3034 in Patients With Solid Tumors With KRASG12D Mutation

Phase 1 study to determine the safety and tolerability of QTX3034 as a single agent or in combination with cetuximab.

Solid Tumors

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Quanta TherapeuticsNCT06227377

Phase 2

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) With Low-Dose Post-Transplant Cyclophosphamide for Prophylaxis of Graft-versus-Host Disease in Hematological Malignancies

This Phase 2, single-arm, open-label study aims to evaluate the safety and efficacy of low-dose (25 mg/kg) post-transplant cyclophosphamide (PTCy) for prophyla…

Graft-versus-Host Disease (GVHD)Hematologic MalignanciesAllogeneic Stem Cell Transplantation

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Milton S. Hershey Medical CenterNCT06926595

Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse (PRIMARY SDM)

This is a qualitative and quantitative study that seeks to obtain information from patients with degenerative mitral valve prolapse and providers regarding fac…

Mitral Valve Prolapse

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Northwell HealthNCT06738537

Phase 1

A First-in-human, Open-label (Part 1), Randomized (Part 2), Phase I/IIa Trial to Study Safety and Tolerability of Multiple Rising Intravitreal Doses of BI 3812465 in Patients With Center-involved Diabetic Macular Edema

This study is open to adults with diabetic macular edema that involves the center of the eye. The purpose of this study is to find out how well different doses…

Diabetic Macular Edema

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Boehringer IngelheimNCT07553429

Phase 3

Ice Compress: Randomized Trial of Limb Cryocompression Versus Continuous Compression Versus Low Cyclic Compression for the Prevention of Taxane-Induced Peripheral Neuropathy

This phase III trial compares the effect of 3 study approaches in preventing chemotherapy-induced peripheral neuropathy: 1) cryocompression, 2) continuous comp…

Malignant Solid Neoplasm

Estimated

~$50 – $2,250

Actual pay is set by the research site.

SWOG Cancer Research NetworkNCT05642611

Phase 4

A Single Center, Open-Label Study to Evaluate the Ability of the iTrace™, BOSA™, OPD-Scan III, and IDRA to Detect Tear Film Stability Utilizing Miebo®

A study to investigate the ability of the iTrace™, BOSA™, OPD-Scan III, and IDRA to detect tear film stability utilizing Miebo®

Dry Eye

Estimated

~$25 – $1,500

Actual pay is set by the research site.

Vance Thompson VisionNCT07790211

Phase 2

Impact of Neoadjuvant Endocrine Therapy on Surgical Outcomes in Patients With Stage 2 to 3 Invasive Lobular Carcinoma: A Prospective Study

The purpose of this study is to look at how effective neoadjuvant (before surgery) endocrine therapy (NET) is in participants with invasive lobular carcinoma (…

Breast CancerHER2-negative Breast CancerHER2 Negative Breast Carcinoma+2 more

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT07483307

Phase 3

Smartphones for Opiate Addiction Recovery

Treatments for opioid addiction exist, but effectiveness is compromised when subjects use illicit opiates during treatment. Reuse rates during treatment can be…

Opioid-use Disorder

Estimated

~$50 – $2,250

Actual pay is set by the research site.

NYU Langone HealthNCT05033028

Phase 2

UCSD Image-Guided Cognitive-Sparing Radiosurgery for Intracranial Lesions: Avoidance of Eloquent White Matter and Hippocampal Regions

In this proposal, the investigators introduce advanced diffusion and volumetric imaging techniques along with innovative, automated image parcellation methods …

Brain Metastases, AdultNeurocognitive FunctionCancer+2 more

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Jona Hattangadi-GluthNCT04343157

Phase 3

A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Dotinurad Compared With Allopurinol in Adult Participants With Hyperuricemia Associated With Gout

The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol in adult pa…

Gout

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Crystalys TherapeuticsNCT07089875

Phase 2

A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)

The purpose of this study is to evaluate the safety and effectiveness of the experimental drug PTX-022 in the treatment of angiokeratomas

Angiokeratomas

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Palvella Therapeutics, Inc.NCT07552077

Observational

Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer

The goal of this clinical trial is to evaluate a screening method to detect clinically relevant prostate cancer. This clinical trial is using genetic data to d…

Prostate CancerPolygenic Risk Score

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Adam S. Kibel, MDNCT06398639